Oncology Archives - Page 5 of 38 - Hospital Healthcare EuropeHospital Healthcare Europe

This website is intended for healthcare professionals only.

Oncology

Stem cell differences could explain why women are more likely to develop adrenal cancer

Stem cell differences could explain why women are more likely to develop adrenal cancer

Using 3D to test personalised cancer treatments in five days

Using 3D to test personalised cancer treatments in five days

New strategy of reprogramming regulatory T cells may improve cancer therapies

New strategy of reprogramming regulatory T cells may improve cancer therapies

Liquid biopsy could identify cancer patients at risk of metastatic disease

Liquid biopsy could identify cancer patients at risk of metastatic disease

Whole body MRI may help to detect spread of cancers more quickly

Whole body MRI may help to detect spread of cancers more quickly

Single dose of targeted radiotherapy is safe and effective for prostate cancer

Single dose of targeted radiotherapy is safe and effective for prostate cancer

Will a simple test for pancreatic cancer really solve the late diagnosis crisis?

Will a simple test for pancreatic cancer really solve the late diagnosis crisis?

HER2 positive breast cancer: treatment de-escalation needs to be personalised

HER2 positive breast cancer: treatment de-escalation needs to be personalised

Continuous chemotherapy improves outcomes and quality of life in advanced breast cancer

Continuous chemotherapy improves outcomes and quality of life in advanced breast cancer

Raising awareness of brachytherapy: a case study

Raising awareness of brachytherapy: a case study

World's first to reproduce complete copy of 'anti-tumour antibiotic'

World’s first to reproduce complete copy of ‘anti-tumour antibiotic’

Blood samples to help select the right early phase clinical trials for cancer patients

Blood samples to help select the right early phase clinical trials for cancer patients

Lynparza approved in EU for germline BRCA-mutated HER2-negative metastatic breast cancer

Lynparza approved in EU for germline BRCA-mutated HER2-negative metastatic breast cancer

ESMO drives EU-level action to tackle shortages of essential medicines

ESMO drives EU-level action to tackle shortages of essential medicines

New treatment combination available first-line to treat advanced kidney cancer

New treatment combination available first-line to treat advanced kidney cancer